First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer

Go back to First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.51 +0.19 (1.84%)
Previous Close $10.32    52 Week High $2.18 
Open $10.47    52 Week Low $0.30 
Day High $10.54    P/E N/A 
Day Low $10.40    EPS $-3.32 
Volume 121,276       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.51 +0.19 (1.84%)
Previous Close $10.32    52 Week High $2.18 
Open $10.47    52 Week Low $0.30 
Day High $10.54    P/E N/A 
Day Low $10.40    EPS $-3.32 
Volume 121,276